Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARS-CoV-2 Human Challenge Characterisation Study
NCT04865237Completed
- Sponsor
- Imperial College London
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Imperial College London. Primary endpoints: Number of Unsolicited Adverse Events in Healthy Participants Challenged With Wild Type SARS-CoV-2, Number of SAEs Related to Viral Challenge and 1 more. Started Mar 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04865237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04865237.